Gustavo Chaud

Gustavo Chaud currently serves as Finance Director for Latin America (excluding Brazil) at BeiGene since November 2023. With extensive experience in finance within the pharmaceutical industry, Gustavo held the position of Oncology Finance Head for Southern Latin America at Novartis from 2007 to September 2022, where responsibilities included delivering approximately $100 million in annual sales and leading strategic financial planning processes. Previous roles at Novartis involved business planning and analysis across multiple divisions, while earlier positions included Financial Controller at Thywill Latam Solutions and Otsuka Pharmaceutical Co., Ltd., as well as Account Analyst at Chemotecnica Sintyal S.A. and Credit Analyst at Banco del Buen Ayre S.A. Eduardo Chaud holds a degree from the University of Buenos Aires, completed between 1995 and 2002.